Structures by: Chow P. S.

Total: 110

Zonisamide-2-hydroxy-5-methylpyridine

C8H8N2O3S,C6H7NO

Aitipamula, SrinivasuluCadden, JosephChow, Pui Shan

CrystEngComm (2018) 20, 21 2923

a=14.1373(3)Å   b=11.23707(18)Å   c=9.45521(17)Å

α=90.00°   β=106.2761(19)°   γ=90.00°

Zonisamide:Caffeine

C8H8N2O3S,C8H10N4O2

Aitipamula, SrinivasuluCadden, JosephChow, Pui Shan

CrystEngComm (2018) 20, 21 2923

a=9.59020(10)Å   b=13.30840(10)Å   c=14.24360(10)Å

α=90°   β=91.8550(10)°   γ=90°

Form II of 1:1 cocrystal of ethenzamide and gentisic acid

C9H11NO2,C7H6O4

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

CrystEngComm (2009) 11, 9 1823

a=7.7217(15)Å   b=12.668(3)Å   c=15.749(3)Å

α=90.00°   β=102.44(3)°   γ=90.00°

Form III of 1:1 cocrystal of ethenzamide and gentisic acid

C9H11NO2,C7H6O4

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

CrystEngComm (2009) 11, 9 1823

a=7.1283(14)Å   b=16.242(3)Å   c=12.904(3)Å

α=90.00°   β=96.25(3)°   γ=90.00°

Form I of 1:1 cocrystal of ethenzamide and gentisic acid

C9H11NO2,C7H6O4

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

CrystEngComm (2009) 11, 9 1823

a=8.0485(16)Å   b=9.1139(18)Å   c=22.607(5)Å

α=94.13(3)°   β=91.52(3)°   γ=113.94(3)°

Form I of 1:1 cocrystal of ethenzamide and saccharin

C9H11NO2,C7H5NO3S

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

CrystEngComm (2009) 11, 5 889

a=7.2141(14)Å   b=7.4923(15)Å   c=15.456(3)Å

α=85.14(3)°   β=86.43(3)°   γ=70.65(3)°

Form II of 1:1 cocrystal of ethenzamide and saccharin

C9H11NO2,C7H5NO3S

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

CrystEngComm (2009) 11, 5 889

a=8.6125(17)Å   b=16.607(3)Å   c=11.183(2)Å

α=90.00°   β=91.45(3)°   γ=90.00°

1:1 Cocrystal of nitrofurantoin and 4-hydroxybenzoic acid

C8H6N4O5,C7H6O3

Vangala, Venu R.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2011) 13, 3 759

a=10.298(2)Å   b=6.4096(13)Å   c=24.680(7)Å

α=90.00°   β=108.08(3)°   γ=90.00°

Nitrofurantoin-pyridine(1:1)

C13H11N5O5

Vangala, Venu R.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2013) 15, 5 878

a=8.3012(17)Å   b=12.940(3)Å   c=14.208(3)Å

α=111.01(3)°   β=96.22(3)°   γ=91.11(3)°

Nitrofurantoin and 2-Picoline(1:1)

C8H6N4O5,C6H7N

Vangala, Venu R.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2013) 15, 5 878

a=7.0324(14)Å   b=22.647(4)Å   c=10.031(4)Å

α=90.00°   β=112.38(2)°   γ=90.00°

1:1:1 solvate of nitrofurantoin, 3-picoline and water

C8H6N4O5,C6H7N,H2O

Vangala, Venu R.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2013) 15, 5 878

a=15.268(6)Å   b=6.4161(19)Å   c=8.461(3)Å

α=90.00°   β=105.286(5)°   γ=90.00°

Nitrofurantoin-3-picoline(1:1)

C14H13N5O5

Vangala, Venu R.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2013) 15, 5 878

a=6.1489(12)Å   b=7.4328(15)Å   c=16.446(3)Å

α=85.35(3)°   β=85.97(3)°   γ=83.67(3)°

1:1 nitrofurantoin and 4-picoline

C8H6N4O5,C6H7N

Vangala, Venu R.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2013) 15, 5 878

a=14.840(3)Å   b=8.0152(16)Å   c=12.951(3)Å

α=90.00°   β=91.12(3)°   γ=90.00°

1:1:1 cocrystal of nitrofurantoin, 2-pyridone and acetonitrile

C8H6N4O5,C5H5NO,C2H3N

Vangala, Venu R.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2013) 15, 5 878

a=8.1736(16)Å   b=9.3544(19)Å   c=11.894(2)Å

α=103.46(3)°   β=109.31(3)°   γ=90.14(3)°

1:1 salt of nitrofurantoin and 4-dimethylaminopyridine

C15H16N6O5

Vangala, Venu R.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2013) 15, 5 878

a=8.616(4)Å   b=26.655(11)Å   c=7.029(3)Å

α=90.00°   β=100.722(9)°   γ=90.00°

1:1:1 cocrystal of nitrofurantoin, 2-pyridone and acetonitrile

C8H6N4O5,C7H8N2O,C2H3N

Vangala, Venu R.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2013) 15, 5 878

a=7.2712(15)Å   b=18.918(4)Å   c=15.451(4)Å

α=90.00°   β=117.41(2)°   γ=90.00°

2-chloro-4-nitrobenzoic acid hydrate

C7H4ClNO4,H2O

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

CrystEngComm (2011) 13, 3 1037

a=7.2871(15)Å   b=7.9395(16)Å   c=8.5516(17)Å

α=117.58(3)°   β=95.80(3)°   γ=93.48(3)°

1,4-dioxane solvate of 2-chloro-4-nitrobenzoic acid

C7H4ClNO4,0.5(C4H8O2)

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

CrystEngComm (2011) 13, 3 1037

a=6.918(3)Å   b=8.368(3)Å   c=9.714(3)Å

α=106.777(2)°   β=93.774(4)°   γ=108.433(5)°

Acetophenone solvate of 2-chloro-4-nitrobenzoic acid

C7H4ClNO4,C8H8O

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

CrystEngComm (2011) 13, 3 1037

a=5.8156(12)Å   b=10.387(2)Å   c=12.207(2)Å

α=83.67(3)°   β=77.63(3)°   γ=81.03(3)°

P-xylene solvate of 2-chloro-4-nitrobenzoic acid

C8H10,2(C7H4ClNO4)

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

CrystEngComm (2011) 13, 3 1037

a=10.790(2)Å   b=11.767(2)Å   c=8.9666(18)Å

α=90.00°   β=90.71(3)°   γ=90.00°

Mesitylene solvate of 2-chloro-4-nitrobenzoic acid

C9H12,2(C7H4ClNO4)

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

CrystEngComm (2011) 13, 3 1037

a=23.088(5)Å   b=12.018(2)Å   c=8.9206(18)Å

α=90.00°   β=110.29(3)°   γ=90.00°

Sulfamerazine-1,4-dioxane (1:1)

C15H20N4O4S

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

CrystEngComm (2012) 14, 2 691

a=11.511(2)Å   b=12.436(3)Å   c=12.095(2)Å

α=90.00°   β=102.05(3)°   γ=90.00°

Sulfamerazine-1,4-dioxane (1:0.5)

C13H16N4O3S

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

CrystEngComm (2012) 14, 2 691

a=7.7675(16)Å   b=8.1233(16)Å   c=12.631(3)Å

α=91.16(3)°   β=95.69(3)°   γ=105.23(3)°

Sulfamerazine-dimethylformamide(1:1)

C11H12N4O2S,C3H7NO

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

CrystEngComm (2012) 14, 2 691

a=9.774(2)Å   b=12.556(3)Å   c=14.659(3)Å

α=76.58(3)°   β=77.57(3)°   γ=86.18(3)°

Sulfamerazine-dimethylacetamide(1:1)

C15H21N5O3S

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

CrystEngComm (2012) 14, 2 691

a=7.6792(15)Å   b=8.3101(17)Å   c=15.125(3)Å

α=93.13(3)°   β=101.81(3)°   γ=104.77(3)°

Sulfamerazine-cyclopentanone(1:1)

C16H20N4O3S

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

CrystEngComm (2012) 14, 2 691

a=5.9650(12)Å   b=9.6479(19)Å   c=14.817(3)Å

α=76.16(3)°   β=83.05(3)°   γ=89.71(3)°

Sulfamerazine-3-Picoline(1:1)

C17H19N5O2S

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

CrystEngComm (2012) 14, 2 691

a=7.8319(16)Å   b=8.1117(16)Å   c=15.358(3)Å

α=76.47(3)°   β=77.04(3)°   γ=73.54(3)°

Monohydrate of Piracetam-4-hydroxybenzoic acid (1:1)

C13H18N2O6

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

CrystEngComm (2012) 14, 7 2381

a=6.4211(13)Å   b=6.6058(13)Å   c=16.590(3)Å

α=96.20(3)°   β=96.76(3)°   γ=90.86(3)°

MOnohydrate of caffeine-4HBA (1:1)

C15H18N4O6

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

CrystEngComm (2012) 14, 7 2381

a=7.2188(14)Å   b=8.5282(17)Å   c=13.827(3)Å

α=90.33(3)°   β=101.29(3)°   γ=107.57(3)°

Oxaprozin-1,2-bis(4-pyridyl)ethane

C18H15NO3,C6H6N

Aitipamula, SrinivasuluWong, Annie B.H.Chow, Pui ShanTan, Reginald B. H.

RSC Adv. (2016)

a=9.7069(19)Å   b=10.878(2)Å   c=10.907(2)Å

α=76.50(3)°   β=68.03(3)°   γ=66.04(3)°

Oxaprozin-Salbutamol

C13H22NO3,C18H14NO3

Aitipamula, SrinivasuluWong, Annie B.H.Chow, Pui ShanTan, Reginald B. H.

RSC Adv. (2016)

a=10.453(2)Å   b=10.627(2)Å   c=13.379(3)Å

α=76.02(3)°   β=69.82(3)°   γ=88.05(3)°

Oxaprozin-4,4'-Bipyridine

C18H15NO3,C5H4N

Aitipamula, SrinivasuluWong, Annie B.H.Chow, Pui ShanTan, Reginald B. H.

RSC Adv. (2016)

a=13.422(3)Å   b=15.305(3)Å   c=18.618(4)Å

α=90.00°   β=103.53(3)°   γ=90.00°

Oxaprozin-2-Amino-3-Picoline

C18H14NO3,C6H9N2

Aitipamula, SrinivasuluWong, Annie B.H.Chow, Pui ShanTan, Reginald B. H.

RSC Adv. (2016)

a=6.0156(12)Å   b=8.8644(18)Å   c=19.296(4)Å

α=81.31(3)°   β=85.29(3)°   γ=80.23(3)°

Oxaprozin-piperazine

C18H14NO3,C2H6N

Aitipamula, SrinivasuluWong, Annie B.H.Chow, Pui ShanTan, Reginald B. H.

RSC Adv. (2016)

a=5.8155(12)Å   b=7.3355(15)Å   c=19.744(4)Å

α=90.14(3)°   β=91.13(3)°   γ=99.08(3)°

DMSO solvate of 2-chloro-4-nitrobenzoic acid

C7H4ClNO4,C2H6OS

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

CrystEngComm (2011) 13, 3 1037

a=5.497(3)Å   b=10.408(4)Å   c=10.594(4)Å

α=74.095(15)°   β=81.029(12)°   γ=85.487(16)°

Oxaprozin

C18H15NO3

Aitipamula, SrinivasuluWong, Annie B.H.Chow, Pui ShanTan, Reginald B. H.

RSC Adv. (2016)

a=10.3129(5)Å   b=7.6460(3)Å   c=36.7642(15)Å

α=90.00°   β=90.00°   γ=90.00°

Triflusal-BA cocrystal

C10H7F3O4,C7H7NO

Aitipamula, SrinivasuluMapp, Lucy K.Wong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2015) 17, 48 9323

a=5.1765(10)Å   b=15.228(3)Å   c=21.041(4)Å

α=90°   β=93.91(3)°   γ=90°

Triflusal-Isonicotinamide cocrystal

C10H7F3O4,C6H6N2O

Aitipamula, SrinivasuluMapp, Lucy K.Wong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2015) 17, 48 9323

a=17.345(7)Å   b=5.1415(17)Å   c=19.447(7)Å

α=90°   β=112.506(5)°   γ=90°

Triflusal-2-Picoliniamide cocrystal

C10H7F3O4,C6H6N2O

Aitipamula, SrinivasuluMapp, Lucy K.Wong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2015) 17, 48 9323

a=5.5536(11)Å   b=11.950(2)Å   c=12.200(2)Å

α=96.01(3)°   β=94.85(3)°   γ=95.99(3)°

Triflusal-urea cocrystal

CH4N2O,2(C10H7F3O4)

Aitipamula, SrinivasuluMapp, Lucy K.Wong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2015) 17, 48 9323

a=14.601(3)Å   b=10.920(2)Å   c=15.342(3)Å

α=90°   β=102.49(3)°   γ=90°

Triflusal-Propionamide cocrystal

C10H7F3O4,C3H7NO

Aitipamula, SrinivasuluMapp, Lucy K.Wong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2015) 17, 48 9323

a=18.729(6)Å   b=9.921(3)Å   c=8.067(3)Å

α=90°   β=97.605(4)°   γ=90°

Triflusal-valpromide cocrystal

C10H7F3O4,C8H17NO

Aitipamula, SrinivasuluMapp, Lucy K.Wong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2015) 17, 48 9323

a=19.8545(8)Å   b=5.06409(17)Å   c=21.8530(11)Å

α=90°   β=114.362(6)°   γ=90°

1:1 ethenzamide and salicylic acid cocrystal

C9H11NO2,C7H6O3

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2012) 14, 24 8515

a=10.679(2)Å   b=9.6670(19)Å   c=14.845(3)Å

α=90.00°   β=106.97(3)°   γ=90.00°

1:1 ethenzamide and vanillic acid cocrystal

C9H11NO2,C8H8O4

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2012) 14, 24 8515

a=13.774(3)Å   b=14.911(3)Å   c=8.0828(16)Å

α=90.00°   β=102.87(3)°   γ=90.00°

1:1 cocrystal of ethenzamide and 2-chloro-4-nitrobenzoic acid

C9H11NO2,C7H4ClNO4

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2012) 14, 24 8515

a=7.7402(15)Å   b=8.3181(17)Å   c=13.216(3)Å

α=76.02(3)°   β=79.85(3)°   γ=84.69(3)°

2:1 ethenzamide and 4-aminobenzoic acid cocrystal

2(C9H11NO2),C7H7NO2

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2012) 14, 24 8515

a=9.0570(18)Å   b=32.685(7)Å   c=8.1857(16)Å

α=90.00°   β=93.39(3)°   γ=90.00°

1:1 ethenzamide and 4-hydroxybenzoic acid

C9H11NO2,C7H6O3

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2012) 14, 24 8515

a=9.4871(19)Å   b=6.4682(13)Å   c=23.703(5)Å

α=90.00°   β=98.65(3)°   γ=90.00°

1:0.5 ethenzamide and fumaric acid cocrystal

C9H11NO2,0.5(C4H4O4)

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2012) 14, 24 8515

a=8.2154(16)Å   b=8.4654(17)Å   c=9.3991(19)Å

α=70.30(3)°   β=71.82(3)°   γ=65.97(3)°

C21H18F3N5O4

C21H18F3N5O4

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2014) 16, 26 5793

a=6.9931(14)Å   b=10.127(2)Å   c=15.112(3)Å

α=95.46(3)°   β=96.70(3)°   γ=101.17(3)°

C19H15F3N2O3

C19H15F3N2O3

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2014) 16, 26 5793

a=7.5628(15)Å   b=7.6450(15)Å   c=14.552(3)Å

α=90.45(3)°   β=92.14(3)°   γ=95.81(3)°

C38H28F6N4O4

C38H28F6N4O4

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2014) 16, 26 5793

a=9.827(2)Å   b=10.361(2)Å   c=25.005(5)Å

α=84.67(3)°   β=81.34(3)°   γ=71.46(3)°

C13H15N3O5

C13H15N3O5

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2013) 15, 29 5877

a=7.0070(14)Å   b=11.224(2)Å   c=16.950(3)Å

α=90.00°   β=91.95(3)°   γ=90.00°

C13H15N3O5

C13H15N3O5

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2013) 15, 29 5877

a=6.8143(14)Å   b=22.419(5)Å   c=8.8759(18)Å

α=90.00°   β=101.85(3)°   γ=90.00°

C16H18N6O6

C16H18N6O6

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2013) 15, 29 5877

a=7.8906(16)Å   b=8.7030(17)Å   c=12.517(3)Å

α=90.00°   β=97.84(3)°   γ=90.00°

C16H18N6O6

C16H18N6O6

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2013) 15, 29 5877

a=3.7036(7)Å   b=7.8401(16)Å   c=29.573(6)Å

α=90.00°   β=90.63(3)°   γ=90.00°

C16H17N5O6

C16H17N5O6

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2013) 15, 29 5877

a=5.0595(10)Å   b=17.246(3)Å   c=19.056(4)Å

α=90.00°   β=97.25(3)°   γ=90.00°

C16H19N5O6

C16H19N5O6

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2013) 15, 29 5877

a=5.1175(10)Å   b=17.467(4)Å   c=18.763(4)Å

α=90.00°   β=96.71(3)°   γ=90.00°

Form I cocrystal of ethenzamide with ethylmalonic acid

C9H11NO2,C5H8O4

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

CrystEngComm (2010) 12, 11 3691

a=7.6928(15)Å   b=8.8062(18)Å   c=11.575(2)Å

α=93.04(3)°   β=108.70(3)°   γ=91.72(3)°

Form II of ethenzamide and ethylmalonic acid cocrystal

C9H11NO2,C5H8O4

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

CrystEngComm (2010) 12, 11 3691

a=14.501(3)Å   b=7.6438(15)Å   c=14.323(3)Å

α=90.00°   β=108.45(3)°   γ=90.00°

Form II cocrystal of 1:1 ethenzamide and ethylmalonic acid cocrystal

C9H11NO2,C5H8O4

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

CrystEngComm (2010) 12, 11 3691

a=14.463(3)Å   b=7.6366(15)Å   c=14.296(3)Å

α=90.00°   β=108.42(3)°   γ=90.00°

Form 1 of 1:1 nicotinamide and pimelic acid

C7H12O4,C6H6N2O

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2012) 14, 23 8193

a=5.4242(11)Å   b=7.3161(15)Å   c=17.917(4)Å

α=99.69(3)°   β=94.01(3)°   γ=103.93(3)°

Form 2 of 1:1 nicotinamide and pimelic acid

C7H12O4,C6H6N2O

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

CrystEngComm (2012) 14, 23 8193

a=9.290(7)Å   b=31.04(2)Å   c=4.981(4)Å

α=90.00°   β=90.00°   γ=90.00°

C15H17NO2,C6H6O2

C15H17NO2,C6H6O2

Lee, Min-JeongAitipamula, SrinivasuluChoi, Guang J.Chow, Pui Shan

Acta Crystallographica Section B (2019) 75, 6

a=7.20150(10)Å   b=12.23260(10)Å   c=21.3487(3)Å

α=90°   β=90°   γ=90°

Polymorph of Agometaline-hydroquinone (1:1) cocrystal

C15H17NO2,C6H6O2,

Lee, Min-JeongAitipamula, SrinivasuluChoi, Guang J.Chow, Pui Shan

Acta Crystallographica Section B (2019) 75, 6

a=7.33300(10)Å   b=29.3095(4)Å   c=8.80460(10)Å

α=90°   β=94.7480(10)°   γ=90°

C19H20ClNO6

C19H20ClNO6

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

Acta crystallographica Section B, Structural science, crystal engineering and materials (2014) 70, Pt 1 54-62

a=11.783(2)Å   b=8.5387(17)Å   c=19.297(4)Å

α=90.00°   β=96.03(3)°   γ=90.00°

C18H20ClNO8

C18H20ClNO8

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

Acta crystallographica Section B, Structural science, crystal engineering and materials (2014) 70, Pt 1 54-62

a=8.5456(17)Å   b=11.740(2)Å   c=19.269(4)Å

α=90.00°   β=90.00°   γ=90.00°

C36H39Cl2NO14

C36H39Cl2NO14

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

Acta crystallographica Section B, Structural science, crystal engineering and materials (2014) 70, Pt 1 54-62

a=8.6852(17)Å   b=15.047(3)Å   c=27.605(6)Å

α=90.00°   β=90.00°   γ=90.00°

C19H22ClNO8

C19H22ClNO8

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

Acta crystallographica Section B, Structural science, crystal engineering and materials (2014) 70, Pt 1 54-62

a=21.931(4)Å   b=8.6541(17)Å   c=11.797(2)Å

α=90.00°   β=117.57(3)°   γ=90.00°

Ethenzamide--gentisic acid--acetic acid (2/1/1)

2(C9H11NO2),C7H6O4,C2H4O2

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B.H.

Acta Crystallographica Section E (2010) 66, 5 o1045-o1046

a=8.8083(18)Å   b=8.8802(18)Å   c=19.880(4)Å

α=93.65(3)°   β=93.55(3)°   γ=119.45(3)°

Pyrimidin-2-amine--1-phenylcyclopentane-1-carboxylic acid (1/1)

C4H5N3,C12H14O2

He, GuangwenAitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

Acta Crystallographica Section E (2011) 67, 3 o552-o553

a=9.1461(18)Å   b=10.490(2)Å   c=15.474(3)Å

α=90.00°   β=98.14(3)°   γ=90.00°

Nitrofurantoin methanol monosolvate

C8H6N4O5,CH4O

Vangala, Venu R.Chow, Pui ShanTan, Reginald B. H.

Acta Crystallographica Section E (2011) 67, 3 o550-o551

a=6.4084(13)Å   b=6.5941(13)Å   c=26.705(5)Å

α=90.00°   β=91.70(3)°   γ=90.00°

1:1 cocrystal of theophylline and gentisic acid

C7H8N4O2,C7H6O4

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

Acta Crystallographica Section E (2009) 65, 9 o2126-o2127

a=7.0989(14)Å   b=8.0543(16)Å   c=13.034(3)Å

α=86.08(3)°   β=81.27(3)°   γ=74.14(3)°

2-Aminopyridinium 1-phenylcyclopropane-1-carboxylate

C5H7N2,C10H9O2

He, GuangwenAitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

Acta Crystallographica Section E (2010) 66, 12 o3339-o3340

a=8.6147(17)Å   b=9.0555(18)Å   c=9.2346(18)Å

α=75.56(3)°   β=87.72(3)°   γ=72.79(3)°

<i>N</i>,<i>N</i>-Dimethylpyridin-4-aminium 1-phenylcyclopentane-1-carboxylate monohydrate

C7H11N2,C12H13O2,H2O

He, GuangwenAitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

Acta Crystallographica Section E (2011) 67, 5 o1227

a=6.1666(12)Å   b=18.206(4)Å   c=15.702(3)Å

α=90.00°   β=97.33(3)°   γ=90.00°

Haloperidol-oxalic acid dihydrate

C44H52Cl2F2N2O10

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2014) 14, 5 2542

a=11.961(2)Å   b=12.954(3)Å   c=14.825(3)Å

α=114.00(3)°   β=99.25(3)°   γ=90.72(3)°

ACN solvate of HAL and OA salt

C46H51Cl2F2N3O8

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2014) 14, 5 2542

a=13.125(3)Å   b=11.996(2)Å   c=26.810(5)Å

α=90.00°   β=90.06(3)°   γ=90.00°

Haloperidol-fumaric acid salt dihydrate

C23H29ClFNO6

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2014) 14, 5 2542

a=8.7151(17)Å   b=10.152(2)Å   c=14.454(3)Å

α=97.42(3)°   β=98.87(3)°   γ=114.92(3)°

Haloperidol-succinic acid salt hydrate

C23H30ClFNO6

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2014) 14, 5 2542

a=8.6026(17)Å   b=10.585(2)Å   c=13.862(3)Å

α=108.39(3)°   β=101.96(3)°   γ=99.31(3)°

Haloperidol-Acetic acid salt dihydrate

C23H31ClFNO6

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2014) 14, 5 2542

a=8.7476(17)Å   b=10.374(2)Å   c=13.837(3)Å

α=105.57(3)°   β=100.04(3)°   γ=96.10(3)°

Haloperidol-Formic acid salt

C23H27ClFNO6

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2014) 14, 5 2542

a=8.4958(17)Å   b=10.032(2)Å   c=26.324(5)Å

α=90.00°   β=94.46(3)°   γ=90.00°

1:1 salt of haloperidol and saccharin

C28H28ClFN2O5S

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2014) 14, 5 2542

a=11.189(2)Å   b=19.890(4)Å   c=12.562(3)Å

α=90.00°   β=114.22(3)°   γ=90.00°

1:1 salt of HAL and CSA

C27H36ClFN2O5S

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2014) 14, 5 2542

a=8.4571(17)Å   b=9.768(2)Å   c=17.989(4)Å

α=87.28(3)°   β=86.32(3)°   γ=68.48(3)°

Form II of a 1:1 salt of HAL and ACE-H

C25H28ClFN2O6S

Aitipamula, SrinivasuluWong, Annie B. H.Chow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2014) 14, 5 2542

a=9.5340(19)Å   b=10.120(2)Å   c=14.360(3)Å

α=88.15(3)°   β=83.73(3)°   γ=65.69(3)°

C14H15FN4O4

C14H15FN4O4

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2014) 14, 12 6557

a=5.0825(10)Å   b=9.7492(19)Å   c=15.148(3)Å

α=77.78(3)°   β=89.74(3)°   γ=77.45(3)°

C14H15FN4O4

C14H15FN4O4

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2014) 14, 12 6557

a=5.2764(11)Å   b=10.181(2)Å   c=13.495(3)Å

α=87.43(3)°   β=81.56(3)°   γ=78.70(3)°

C15H15FN2O6

C15H15FN2O6

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2014) 14, 12 6557

a=5.1227(10)Å   b=21.618(4)Å   c=13.215(3)Å

α=90.00°   β=93.39(3)°   γ=90.00°

C15H19FN6O6

C15H19FN6O6

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2014) 14, 12 6557

a=8.4887(17)Å   b=8.6643(17)Å   c=12.184(2)Å

α=91.83(3)°   β=100.87(3)°   γ=105.30(3)°

C14H15FN2O6

C14H15FN2O6

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2014) 14, 12 6557

a=12.609(3)Å   b=11.125(2)Å   c=19.976(4)Å

α=90.00°   β=92.16(3)°   γ=90.00°

Metaxalone

C12H15NO3

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2011) 11, 9 4101

a=5.5559(11)Å   b=10.321(2)Å   c=19.819(4)Å

α=82.82(3)°   β=88.63(3)°   γ=82.49(3)°

1:1 Cocrystal of nitrofurantoin and 3-aminobenzoic acid

C8H6N4O5,C7H7NO2

Vangala, Venu R.Chow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2012) 12, 12 5925

a=9.1485(18)Å   b=9.4656(19)Å   c=9.903(2)Å

α=107.39(3)°   β=98.66(3)°   γ=97.17(3)°

1:1 Cocrystal of nitrofurantoin and 4-aminobenzoic acid

C8H6N4O5,C7H7NO2

Vangala, Venu R.Chow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2012) 12, 12 5925

a=6.7539(14)Å   b=7.4546(15)Å   c=16.032(3)Å

α=92.64(3)°   β=91.81(3)°   γ=102.47(3)°

Form I 1:1 cocrystal of ethenzamide and 3,5-dinitrobenzoic acid

C9H11NO2,C7H4N2O6

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2010) 10, 5 2229

a=7.7552(16)Å   b=14.875(3)Å   c=14.587(3)Å

α=90.00°   β=99.28(3)°   γ=90.00°

0.5 acetone solvate of 1:1 cocrystal of ethenzamide and 3,5-dinitrobenzoic acid

2(C9H11NO2),2(C7H4N2O6),C3H6O

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2010) 10, 5 2229

a=7.6784(15)Å   b=8.1720(16)Å   c=15.642(3)Å

α=103.82(3)°   β=91.93(3)°   γ=100.39(3)°

0.5 dioxane solvate of 1:1 cocrystal of ethenzamide and 3,5-dinitrobenzoic acid

C9H11NO2,C7H4N2O6,0.5(C4H8O2)

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2010) 10, 5 2229

a=7.6623(15)Å   b=8.3247(17)Å   c=15.362(3)Å

α=99.74(3)°   β=91.75(3)°   γ=102.04(3)°

0.5 thf solvate of 1:1 cocrystal of ethenzamide and 3,5-dinitrobenzoic acid

2(C9H11NO2),2(C7H4N2O6),C4H8O

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2010) 10, 5 2229

a=7.6358(15)Å   b=8.3248(17)Å   c=15.291(3)Å

α=99.50(3)°   β=91.41(3)°   γ=102.29(3)°

Toluene solvate of 1:1 cocrystal of ethenzamide and 3,5-dinitrobenzoic acid

C9H11NO2,C7H4N2O6

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2010) 10, 5 2229

a=7.5321(15)Å   b=8.5532(17)Å   c=16.039(3)Å

α=105.44(3)°   β=92.71(3)°   γ=103.57(3)°

Ethylacetate solvate of 1:1 cocrystal of ethenzamide and 3,5-dinitrobenzoic acid

C9H11NO2,C7H4N2O6

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2010) 10, 5 2229

a=7.6503(15)Å   b=8.1921(16)Å   c=15.810(3)Å

α=104.91(3)°   β=92.45(3)°   γ=99.99(3)°

P-xylene solvate of 1:1 cocrystal of ethenzamide and 3,5-dinitrobenzoic acid

C9H11NO2,C7H4N2O6

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2010) 10, 5 2229

a=7.5327(15)Å   b=8.4169(17)Å   c=15.847(3)Å

α=103.47(3)°   β=93.06(3)°   γ=101.52(3)°

Mesitylene solvate of 1:1 cocrystal of ethenzamide and 3,5-dinitrobenzoic acid

C9H11NO2,C9H12,C7H4N2O6

Aitipamula, SrinivasuluChow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2010) 10, 5 2229

a=7.5121(15)Å   b=11.316(2)Å   c=28.712(6)Å

α=90.00°   β=90.68(3)°   γ=90.00°

1:1 cocrystal of nitrofurantoin and urea

C8H6N4O5,CH4N2O

Vangala, Venu R.Chow, Pui ShanTan, Reginald B. H.

Crystal Growth & Design (2012) 12, 12 5925

a=6.6779(13)Å   b=13.648(3)Å   c=14.003(4)Å

α=90.00°   β=110.95(3)°   γ=90.00°